Package 71288-165-54

{"route": ["INTRAVENOUS"], "spl_id": "6e728854-7685-4806-8edb-e2a3fc055c7d", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["60158CV180"], "rxcui": ["603566"], "spl_set_id": ["21919314-5c25-49ab-beba-099983ed4a71"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (71288-165-54)  / 50 mL in 1 VIAL, SINGLE-DOSE (71288-165-52)", "package_ndc": "71288-165-54", "marketing_start_date": "20230110"}], "brand_name": "Nelarabine", "product_id": "71288-165_6e728854-7685-4806-8edb-e2a3fc055c7d", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "71288-165", "generic_name": "Nelarabine", "labeler_name": "Meitheal Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nelarabine", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "ANDA216038", "marketing_category": "ANDA", "marketing_start_date": "20230110", "listing_expiration_date": "20261231"}